9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

A Study in Non Small Cell Lung Cancer

A Study in Non Small Cell Lung Cancer

Estimated reading time: < 1 min

Condition: Non Small Cell Lung Cancer

Estimated Enrollment: 76

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: Has Results

Outcome Measures: Phase 2: Progression-Free Survival Time,  Phase 1: Recommended Phase 2 Dose of LY2603618,  Phase 2: Overall Survival, Phase 2: Overall Tumor Response Rate: Percentage of Participants Who Achieved a Confirmed Best Response of Completed Response (CR) or Partial Response (PR)

Interventions: Pemetrexed, Cisplatin

Phase:

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date: May 2013

Completion Date: August 2014

Last  Posted Date: May 18, 2018

Location: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon – Fri from 9 AM to 5 PM Eastern Time (UTC/GMT – 5 hours, EST), or speak with your personal physician., Mannheim, Baden-Wurttemberg, Germany

Website Link: https://ClinicalTrials.gov/show/NCT01139775

Was this article helpful?
Dislike 0